1Suppliers
3Customers
2Debt Items
19Related Chains

Candel Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
GNLX Genelux Corporation 72% Reciprocal relationship from GNLX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from GNLX graph: Reciprocal relationship from CADL graph: Reciprocal relationship from GNLX g…

Candel Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
VENTAGEN VENTAGEN 92% Ventagen agreed to purchase from the Company all manufactured product that is required for clinical or commercial purposes at a price of cost plus 25 % of the wholesale price of the approved product
GNLX Genelux Corporation 72% Reciprocal relationship from GNLX graph: ials between batches from a single supplier or between suppliers; ● the possible breach by our third-party suppliers and service providers of our agreements w…
TOVX Theriva Biologics, Inc. 72% Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the app…

Candel Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CADL-DEBT Debt stack $49.3M 90% Market cache reports total debt of $49.3M.
CADL-DEBT-8450 Warrants outstanding: 430000 90% xbrl warrant detail from xbrl 2025-12-31.

Candel Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Candel Therapeutics, Inc..

Candel Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
CADL-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 115 tracked holders.

Candel Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TSHA Taysha Gene Therapies, Inc. 100.00 2
GNLX Genelux Corporation 100.00 1 ['customer', 'supplier']
TOVX Theriva Biologics, Inc. 100.00 1 ['customer']
RPID Rapid Micro Biosystems, Inc. 100.00 2
SI Shoulder Innovations, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 50.00 2
BMYMP Bristol-Myers Squibb Co 50.00 2
ONCY Oncolytics Biotech Inc. 50.00 2
MCRB Seres Therapeutics, Inc. 50.00 2
LLY Eli Lilly and Company 50.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
CORZ Core Scientific, Inc. 50.00 2
REGN Regeneron Pharmaceuticals, Inc. 50.00 2
CGON CG Oncology, Inc. 50.00 2
CLDWW Calidi Biotherapeutics, Inc. 50.00 2
REPL Replimune Group, Inc. 50.00 2
IOVA Iovance Biotherapeutics, Inc. 50.00 2
JNJ Johnson & Johnson 50.00 2
TRIN Trinity Capital Inc. 38.88 1 ['receiving']